TKNO logo

TKNO Alpha Teknova, Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$7.63
-0.18 (-2.30%)

Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompas…

Market Cap: $479.95Mwww.teknova.com

Price

No data yet.

Social Signal Score

54
5d
70
1 mentions
—
30d
55
4 mentions
—
60d
46
12 mentions
—
90d
46
14 mentions
—
news: 14

Analyst Ratings

4 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 0Sell 0Strong Sell 0
Avg price target$8+4.8%
Low $7Median $8High $9
Current Consensus

Revenue

$12.70M+107.85%
$6.04M$8.26M$10.48M$12.70M
Mar 2020Sep 2026

Analyst Estimates

FY2025
$-0.33
$-0.34–$-0.32
3 analysts
FY2026
$-0.28
$-0.30–$-0.24
3 analysts
FY2027
$-0.22
$-0.27–$-0.16
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Stephen Gunstream
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
158
Beta
0.73
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
6.33
www.teknova.com